Full-Time

Commissioning and Qualification Project Manager

Posted on 4/28/2025

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

No salary listed

Senior, Expert

Bridgewater Township, NJ, USA

Hybrid work arrangement; specific number of in-office days not mentioned.

Category
Project Management
Business & Strategy
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • B.Sc./M.Sc. in Biological/Biochemical Science/Bioengineering related field or equivalent work experience. Trade / Technical School Certification or Certification in Craft. Military equivalent of Trade / Technical School certification.
  • A minimum of 7 years’ experience in a regulated industry and 3 years’ experience of direct qualification project management. Preferred candidate would have previous experience working for a cell and gene therapy organization.
  • Must be able to read drawings, schematics, and isometrics. Must have basic computer skills in Microsoft Word, Excel, and PowerPoint. Must be proficient utilizing a computerized maintenance management program and qualification software.
  • An ability to build strong partnerships and effectively integrate with external collaborators to drive projects/programs forward in a matrixed environment.
  • Must be able to manage shifting priorities to meet critical deadlines in a fast paced and dynamic, growing environment, while providing clear direction to team members.
  • A history of developing and building cohesive, high performing teams with a strong sense of mission, providing training and mentoring to build sufficient management depth throughout the organization and ensure strong succession planning.
  • Excellent teamwork and interpersonal skills with ability to influence and build strong working relationships at all levels within the organization.
  • Advanced knowledge of facility operations including best industry practices, application of principles, concepts, practices, standards, validation, and qualification within a cGMP manufacturing environment.
  • Maintains accurate working knowledge of governmental/regulatory requirements as related to equipment including EPA, OSHA, and the FDA. Monitors and ensures company compliance with regulatory standards.
  • Excellent organizational and communication skills.
Responsibilities
  • Interface between the Engineering group and the operating departments to address internal stakeholder needs ensuring that all asset qualification activities are properly supporting for manufacturing, quality control, supply operations and for the site’s requirement.
  • Drive the establishment of the aforementioned processes, while ensuring a safe, compliant, and efficient operation with the establishment of appropriate controls and traceability according to cGMP requirements.
  • Support and manage change controls, draft and review SOPs and protocols, support technical investigations, and implement CAPAs to address compliance requirements.
  • Responsible for maintaining assets in a qualified state in accordance with quality standards, Good Manufacturing Practices, and OEM guidelines.
  • Develop/improve, implement, and execute the qualification program for Legend Biotech.
  • Lead and direct qualification activities to meet company goals, quality, and regulatory objectives. Qualification team will consist of managing external resources and some internal resources.
  • Ensure safety, quality, and compliance is the main goal for all new and existing qualification projects.
  • Prepare Requests for Proposal (RFP) documents for vendors to bid qualification work. Provide vendor comparisons and award qualified vendors.
  • Provide SME support for regulatory inspections and regulatory filings.
  • Author/Review/Approve documents for departmental standard operating procedures (SOPs) and programs.
  • Generation and execution of qualification documents URS, RA, SAT, FAT, IQ, OQ, PQ, and summary reports to support GxP requirements.
  • Review of new qualification project proposals and project prioritization/scheduling efforts to keep activities aligned to corporate objectives.
  • Ensures necessary communication within the project engineering team and collaborate with other departments (Manufacturing, Quality, Regulatory, Development, Finance, and IT) on qualification deliverables.
  • Provide qualification project updates to stakeholders and management personnel, such as phase gate reviews, meeting minutes, status updates, and identification and tracking of project risks.
  • Demonstrate effective project leadership and team collaboration by completing all assigned projects on-time, on budget and successfully achieving qualification expectations in compliance with our safety policies and company regulations.
  • Manages / oversees external vendors to ensure qualification activities are maintained to the highest standards.
  • Author and execute Change Controls and Impact Assessments for Engineering/Facilities qualification projects.
  • Participate and lead in the development of corporate-wide systems, procedures, and tools that facilitate efficient processes throughout the organization.
Desired Qualifications
  • Cell/Gene Therapy experience preferred.

Legend Biotech develops and sells cell therapies aimed at treating serious diseases, particularly cancers affecting the blood and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company focuses on personalized medicine, which tailors therapies to individual patients. They not only discover and develop new therapies but also bring them to market, generating revenue through licensing and sales, such as their CAR-T therapies that modify patients' own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial performance and business developments. Their goal is to provide effective treatments for hard-to-treat diseases.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Franklin Township, New Jersey

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • $150M investment in Belgium facility shows commitment to expanding production capabilities.
  • Alan Bash's appointment strengthens leadership in CAR-T therapy market.
  • New R&D facility in Philadelphia focuses on next-generation cell therapies.

What critics are saying

  • Increased competition from Amgen's Imdelltra could impact market share.
  • Collaboration with Multiply Labs may face challenges in scaling up production.
  • Expansion of R&D facilities requires significant investment, potentially straining resources.

What makes Legend Biotech unique

  • Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
  • The company is technology agnostic, exploring multiple platforms for effective treatments.
  • Legend Biotech's business model includes discovery, development, and commercialization of therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Fierce Pharma
Mar 12th, 2025
J&J, Legend to invest $150M in Belgium cell therapy facility as new Carvykti rival looms

J&J, Legend to invest $150M in Belgium cell therapy facility as new Carvykti rival looms.

The Yellow Brick Road
Mar 3rd, 2025
YB new stock pitches (Mon, Mar 3)

Legend Biotech Corporation (LEGN) is developing a promising CAR-T cancer drug in partnership with Johnson & Johnson.

ROI-NJ
Nov 5th, 2024
Legend Biotech Names Alan Bash As Leader Of Its Cer-T Product

Legend Biotech Corporation on Tuesday said it appointed Alan Bash as president of its CAR-T product CARVYKTI®. In this newly created role, Bash will be responsible for managing the continued growth of CARVYKTI®, overseeing the Somerset-based firm’s commercial, technical operations, and quality functions of the franchise.“This expansion in our leadership structure is on the heels of CARVYKTI’s recent successes, including recent approvals from the U.S. Food and Drug Administration and European Commission for label expansion,” Ying Huang, chief executive officer of Legend Biotech said. “Legend Biotech welcomes Alan and is confident that his wealth of operational knowledge in oncology will help further strengthen the Company’s leadership role in the treatment of multiple myeloma.”Previously, Bash served as chief executive officer for two oncology-focused biotech companies, most recently at ZielBio, and before that, as president and CEO at Checkmate Pharmaceuticals. He also had a 23-year career with Bristol Myers Squibb, where he held various leadership positions across all major therapeutic areas—including oncology—driving the U.S. launch of Opdivo® and the expansion of additional cancer treatments such as Yervoy® and Erbitux ®.Bash contributed to several blockbuster products in collaboration with other companies, including Abilify® with Otsuka and Eliquis® with Pfizer.“As the fastest launched CAR-T product on the market, CARVYKTI has already produced impressive momentum,” Bash said

GlobeNewswire
Nov 4th, 2024
Legend Biotech Appoints Alan Bash As President Of Carvykti(R)

SOMERSET, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Alan Bash as the Company’s President of CARVYKTI®. In this newly created role, Mr. Bash will be responsible for managing the continued growth of CARVYKTI®, overseeing Legend Biotech’s commercial, technical operations, and quality functions of the franchise.“This expansion in our leadership structure is on the heels of CARVYKTI’s recent successes, including recent approvals from the U.S. Food and Drug Administration and European Commission for label expansion,” said Ying Huang, Ph.D., Chief Executive Officer of Legend Biotech. “Legend Biotech welcomes Alan and is confident that his wealth of operational knowledge in oncology will help further strengthen the Company’s leadership role in the treatment of multiple myeloma.”Mr

BioBuzz
Oct 30th, 2024
Legend Biotech Chooses Philadelphia for New R&D Center

With a global workforce of 1,500 employees, including 350 in R&D, Legend is expanding its manufacturing capabilities with new facilities in New Jersey and beyond.